Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Americans report stable personal well being but declining national confidence

24

Feb 2026

Americans report stable personal well being but declining national confidence

American reports of individual well-being have remained relatively stable over decades, but confidence in the nation has sharply declined. James N. Druckman and colleagues analyzed long-term survey data from two National Science Foundation-supported infrastructure projects: the General Social Survey and the American National Election Studies.

Study reframes amygdala as the sophisticated learning arbiter

24

Feb 2026

Study reframes amygdala as the sophisticated learning arbiter

A Dartmouth study challenges the conventional view that the amygdala-the two-sided structure deep in the brain involved in emotion, learning, and decision making-is simply the brain's primitive "fear center," reflexively driving us to avoid the things we fear, from high places and tight spaces to spiders and large crowds.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.